Additional studies will be necessary to determine the exact mechanisms behind this genomic and regulatory pattern of SIX1 in ES, and any additional characteristics of the ES context beyond EWS/FLI1 expression which may be responsible for this anti-metastatic function of SIX1. This evidence concerns the gene FLI1 and Ewing sarcoma.